The preparation and SAR of 4-(anilino), 4-(phenoxy), and 4-(thiophenoxy)-quinazolines: Inhibitors of p56(lck) and EGF-R tyorsine kinase activity

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 4, 1997, Pages 417-420

  Myers, Michael R ^a   Setzer, Natalie N ^a   Spada, Alfred P ^a   Zulli, Allison L ^a   Hsu, Chin Yi J ^a   Zilberstein, Asher ^a   Johnson, Susan E ^a   Hook, Linda E ^a   Jacoski, Mary V ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; QUINAZOLINE DERIVATIVE; RPR 1085185A; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; LEUKEMIA CELL LINE; PROTEIN PHOSPHORYLATION; STRUCTURE ACTIVITY RELATION;

EID: 0031576843     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00034-6     Document Type: Article

References (34)

1. 1. Partially disclosed in Myers, M. R.; Spada, A. P.; Maguire, M. P.; Persons, P. E.; Zilberstein, A., Hsu, C.-Y.; Johnson, S., WO PCT Appl. 95/15758, 1995.
2. 2. Bolen, J. B.; Rowley, R. B.; Spana, C.; Tsygankov, A. Y. FASEB J. 1992, 3403. Mustelin, T.; Burn, P. TIBS 1993, 215. Eichmann, K. Angew. Chem. Int. Ed. Eng. 1993, 54. Klausner, R. D.; Samelson, L. E. Cell 1991, 875.
3. Bolen, J. B.; Rowley, R. B.; Spana, C.; Tsygankov, A. Y. FASEB J. 1992, 3403. Mustelin, T.; Burn, P. TIBS 1993, 215. Eichmann, K. Angew. Chem. Int. Ed. Eng. 1993, 54. Klausner, R. D.; Samelson, L. E. Cell 1991, 875.
4. Bolen, J. B.; Rowley, R. B.; Spana, C.; Tsygankov, A. Y. FASEB J. 1992, 3403. Mustelin, T.; Burn, P. TIBS 1993, 215. Eichmann, K. Angew. Chem. Int. Ed. Eng. 1993, 54. Klausner, R. D.; Samelson, L. E. Cell 1991, 875.
5. Bolen, J. B.; Rowley, R. B.; Spana, C.; Tsygankov, A. Y. FASEB J. 1992, 3403. Mustelin, T.; Burn, P. TIBS 1993, 215. Eichmann, K. Angew. Chem. Int. Ed. Eng. 1993, 54. Klausner, R. D.; Samelson, L. E. Cell 1991, 875.
6. 3. Tamaoki, T.; Nomoto, H.; Takahashi, I.; Kato, Y.; Morimoto, M.; Tomita, F. Biochem. Biophys. Res. Comm. 1986, 135, 397. Herbert, J. M.; Seban, E.; Maffrand, J. P. Biochem. Biophys. Res. Comm. 1990, 171, 189.
7. Tamaoki, T.; Nomoto, H.; Takahashi, I.; Kato, Y.; Morimoto, M.; Tomita, F. Biochem. Biophys. Res. Comm. 1986, 135, 397. Herbert, J. M.; Seban, E.; Maffrand, J. P. Biochem. Biophys. Res. Comm. 1990, 171, 189.
8. 4. Hagiwara, M.; Inoue, S.; Tamaka, T.; Nunoki, K.; Ito, M. Hidaka, H. Biochem. Pharm. 1988, 37, 2987. Cushman, M.; Nagarathnam, D.; Geahlen, R. L. J. Nat. Prod. 1991, 54, 1345. Cushman, M.; Zhu, H.; Geahlen, R. L.; Kraker, A. J. J. Med. Chem. 1994, 37, 3353. Miller, D.; Wang, S.; Reid, J.; Xie, W.; Gauvin, B.; Kelley, M.; Sarup, J.; Sawutz, D. G.; Miski, M.; Dolle, R. E.; Faltynek, C. R. Drug Development Res. 1995, 34, 344.
9. Hagiwara, M.; Inoue, S.; Tamaka, T.; Nunoki, K.; Ito, M. Hidaka, H. Biochem. Pharm. 1988, 37, 2987. Cushman, M.; Nagarathnam, D.; Geahlen, R. L. J. Nat. Prod. 1991, 54, 1345. Cushman, M.; Zhu, H.; Geahlen, R. L.; Kraker, A. J. J. Med. Chem. 1994, 37, 3353. Miller, D.; Wang, S.; Reid, J.; Xie, W.; Gauvin, B.; Kelley, M.; Sarup, J.; Sawutz, D. G.; Miski, M.; Dolle, R. E.; Faltynek, C. R. Drug Development Res. 1995, 34, 344.
10. Hagiwara, M.; Inoue, S.; Tamaka, T.; Nunoki, K.; Ito, M. Hidaka, H. Biochem. Pharm. 1988, 37, 2987. Cushman, M.; Nagarathnam, D.; Geahlen, R. L. J. Nat. Prod. 1991, 54, 1345. Cushman, M.; Zhu, H.; Geahlen, R. L.; Kraker, A. J. J. Med. Chem. 1994, 37, 3353. Miller, D.; Wang, S.; Reid, J.; Xie, W.; Gauvin, B.; Kelley, M.; Sarup, J.; Sawutz, D. G.; Miski, M.; Dolle, R. E.; Faltynek, C. R. Drug Development Res. 1995, 34, 344.
11. Hagiwara, M.; Inoue, S.; Tamaka, T.; Nunoki, K.; Ito, M. Hidaka, H. Biochem. Pharm. 1988, 37, 2987. Cushman, M.; Nagarathnam, D.; Geahlen, R. L. J. Nat. Prod. 1991, 54, 1345. Cushman, M.; Zhu, H.; Geahlen, R. L.; Kraker, A. J. J. Med. Chem. 1994, 37, 3353. Miller, D.; Wang, S.; Reid, J.; Xie, W.; Gauvin, B.; Kelley, M.; Sarup, J.; Sawutz, D. G.; Miski, M.; Dolle, R. E.; Faltynek, C. R. Drug Development Res. 1995, 34, 344.
12. 5. Burke, T. R.; Ford, H.; Osherov, N.; Levitzki, A.; Stefanova, I.; Horak, I. D.; Marquez, V. E. Bioorg. Med. Chem. Lett. 1992, 1771. Smyth, M. S.; Stefanova, I.; Hartmann, F.; Horak, I. D.; Osherov, N.; Levitzki, A.; Burke, J. T. R. J. Med. Chem. 1993, 3010. Smyth, M. S.; Stefanova, I.; Horak, I. D.; Burke, J. T. R. J. Med. Chem. 1993, 3015. Showalter, H. D. H. Chemtracts 1993, 258.
13. Burke, T. R.; Ford, H.; Osherov, N.; Levitzki, A.; Stefanova, I.; Horak, I. D.; Marquez, V. E. Bioorg. Med. Chem. Lett. 1992, 1771. Smyth, M. S.; Stefanova, I.; Hartmann, F.; Horak, I. D.; Osherov, N.; Levitzki, A.; Burke, J. T. R. J. Med. Chem. 1993, 3010. Smyth, M. S.; Stefanova, I.; Horak, I. D.; Burke, J. T. R. J. Med. Chem. 1993, 3015. Showalter, H. D. H. Chemtracts 1993, 258.
14. Burke, T. R.; Ford, H.; Osherov, N.; Levitzki, A.; Stefanova, I.; Horak, I. D.; Marquez, V. E. Bioorg. Med. Chem. Lett. 1992, 1771. Smyth, M. S.; Stefanova, I.; Hartmann, F.; Horak, I. D.; Osherov, N.; Levitzki, A.; Burke, J. T. R. J. Med. Chem. 1993, 3010. Smyth, M. S.; Stefanova, I.; Horak, I. D.; Burke, J. T. R. J. Med. Chem. 1993, 3015. Showalter, H. D. H. Chemtracts 1993, 258.
15. Burke, T. R.; Ford, H.; Osherov, N.; Levitzki, A.; Stefanova, I.; Horak, I. D.; Marquez, V. E. Bioorg. Med. Chem. Lett. 1992, 1771. Smyth, M. S.; Stefanova, I.; Hartmann, F.; Horak, I. D.; Osherov, N.; Levitzki, A.; Burke, J. T. R. J. Med. Chem. 1993, 3010. Smyth, M. S.; Stefanova, I.; Horak, I. D.; Burke, J. T. R. J. Med. Chem. 1993, 3015. Showalter, H. D. H. Chemtracts 1993, 258.
16. 6. Faltynek, C. R.; Schroeder, J.; Mauvais, P.; Miller, D.; Wang, S.; Murphy, D.; Lehr, R.; Kelley, M.; Maycock, A.; Michne, W.; Miski, M.; Thunberg, A. L. Biochemistry 1995, 34, 12404.
17. 7. Hanke, J. H.; Gardner, J. P.; Dow, R. L.; Changelian, P. S.; Brissette, W. H.; Weringer, E. J.; Pollock, B. A., Connelly, P. A., J. Biol. Chem. 1996, 271, 695.
18. 8. Barker, A.; Davies, D. H., EP Appl. 520722, 1992. Barker, A. J., EP Appl. 566226, 1993. Barker, A. J., Brown, D. S., EP Appl. 602851, 1994. Barker, A. J., EP Appl. 635498, 1995. The EGF-R activity of 4 has been reported previously: Levitzki A, Gazit A. Science 1995, 267, 1782.
19. Barker, A.; Davies, D. H., EP Appl. 520722, 1992. Barker, A. J., EP Appl. 566226, 1993. Barker, A. J., Brown, D. S., EP Appl. 602851, 1994. Barker, A. J., EP Appl. 635498, 1995. The EGF-R activity of 4 has been reported previously: Levitzki A, Gazit A. Science 1995, 267, 1782.
20. Barker, A.; Davies, D. H., EP Appl. 520722, 1992. Barker, A. J., EP Appl. 566226, 1993. Barker, A. J., Brown, D. S., EP Appl. 602851, 1994. Barker, A. J., EP Appl. 635498, 1995. The EGF-R activity of 4 has been reported previously: Levitzki A, Gazit A. Science 1995, 267, 1782.
21. Barker, A.; Davies, D. H., EP Appl. 520722, 1992. Barker, A. J., EP Appl. 566226, 1993. Barker, A. J., Brown, D. S., EP Appl. 602851, 1994. Barker, A. J., EP Appl. 635498, 1995. The EGF-R activity of 4 has been reported previously: Levitzki A, Gazit A. Science 1995, 267, 1782.
22. Barker, A.; Davies, D. H., EP Appl. 520722, 1992. Barker, A. J., EP Appl. 566226, 1993. Barker, A. J., Brown, D. S., EP Appl. 602851, 1994. Barker, A. J., EP Appl. 635498, 1995. The EGF-R activity of 4 has been reported previously: Levitzki A, Gazit A. Science 1995, 267, 1782.
23. 9. (a) Fry, D. W.; Kraker, A. J., McMichael, A.; Ambroso, L. A.; Nelson, J. M.; Leopold, W. R.; Connors, R. W.; Bridges, A. J. Science 1994, 265, 1093.
24. (b) Bridges, A. J. Exp. Opin. Ther. Patents 1995, 5, 1245 and references therein.
25. (c) Bridges, A. J.; Cody, D. R.; Zhou, H.; McMichael, A.; Fry, D. W. Bioorg. Med. Chem. 1995, 3, 1651.
26. 10. Traxler, P. M.; Furet, P.; Mett, H.; Buchdunger, E.; Meyer, T. ; Lydon, N. J. Med. Chem. 1996, 39, 2285.
27. 11. (a) Spada, A. P., Persons, P. E.; Levitzki, A.; Gilon, C.; Gazit, A. WO PCT 91/16501, publ. Oct. 31, 1991.
28. (b) Spada, A. P. ; Maguire, M. P.; Persons, P.; Myers, M. R., WO PCT 92/20642, publ. Nov. 26, 1992.
29. (c) Maguire, M.; Sheets, K. R.; McVety, K.; Spada, A. P.; Zilberstein, A. J. Med. Chem. 1994, 37, 2129.
30. 12. Niementowski, S. J. Prakt. Chem. 1895, 51, 564.
31. 13. Kreutzberger, A.; Uzbek, M. U. Arch. Pharm. 1972, 305, 171.
32. 50's were from a minimum of two separate experiments.
33. 15. See following communication in this journal.
34. 16. Experiments performed by Dr. E. Rabin, RPR.